|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | -.--% |
|
-1.96% | +9.89% |
| 06-03 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 06-01 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | 1.97x | 20.32x | 43.14x | 61.29M | |
| -.--% | -.--% | 15.48x | 1.36x | 0.59x | 9.28x | 9.97x | 13.38B | |
| -.--% | 1.08% | 19.09x | 2.33x | 0.91x | 14.13x | 14.44x | 6.35B | |
| 2.36% | 2.67% | 15.79x | 1.65x | 0.7x | 7.32x | 9.23x | 5.62B | |
| 4.12% | 4.53% | 15.67x | 7.09x | 0.95x | 7.1x | 9.87x | 3.31B | |
| 5.74% | 6.38% | 14.4x | 4.32x | 1.22x | 7.42x | 14.39x | 3.24B | |
| 3.79% | 4.19% | 11.34x | 1.71x | 0.71x | 5.1x | 6.68x | 3.4B | |
| 5.99% | 6.32% | 11.53x | 2.16x | 0.45x | 3.62x | 5.97x | 2.71B | |
| 1.75% | 2.12% | 23.44x | 4.1x | 0.67x | 8.6x | 14.08x | 1.73B | |
| 0.01% | -.--% | -87.21x | 2.87x | 0.46x | 17.07x | 103.22x | 1.6B | |
| 5.61% | 6.31% | 11.81x | 2.38x | 0.87x | 7.07x | 13.34x | 995M | |
| 4.94% | 5.57% | 10.27x | 0.73x | 0.23x | 2.25x | 4.64x | 851M | |
| 1.35% | 1.95% | 27.13x | 7.31x | 0.97x | 13.31x | 21.1x | 803M | |
| Average | 2.97% | 3.43% | 7.39x | 3.17x | 0.82x | 9.43x | 20.78x | 3.39B | |
| Weighted average by Cap. | 2.01% | 2.39% | 12.03x | 2.55x | 0.73x | 8.92x | 14.10x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
